MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
S Yamamura, M Eslam, T Kawaguchi… - Liver …, 2020 - Wiley Online Library
Abstract Background & Aims Diagnostic criteria for metabolic associated fatty liver disease
(MAFLD) have been proposed, but not validated. We aimed to compare the diagnostic …
(MAFLD) have been proposed, but not validated. We aimed to compare the diagnostic …
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
ME Sakura Yamamura, T Kawaguchi, T Tsutsumi… - Liver …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background & Aims</jats: title><
jats: p> Diagnostic criteria for metabolic associated fatty liver disease (MAFLD) have been …
jats: p> Diagnostic criteria for metabolic associated fatty liver disease (MAFLD) have been …
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD.
S Yamamura, M Eslam, T Kawaguchi… - Liver …, 2020 - search.ebscohost.com
Abstract Background & Aims: Diagnostic criteria for metabolic associated fatty liver
disease (MAFLD) have been proposed, but not validated. We aimed to compare the …
disease (MAFLD) have been proposed, but not validated. We aimed to compare the …
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
S Yamamura, M Eslam, T Kawaguchi, T Tsutsumi… - 2020 - wslhd.intersearch.com.au
BACKGROUND & AIMS: Diagnostic criteria for metabolic associated fatty liver disease
(MAFLD) have been proposed, but not validated. We aimed to compare the diagnostic …
(MAFLD) have been proposed, but not validated. We aimed to compare the diagnostic …
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD.
S Yamamura, M Eslam, T Kawaguchi… - … : Official Journal of the …, 2020 - europepmc.org
Methods We enrolled 765 Japanese patients with fatty liver (median age 54 years). MAFLD
and NAFLD were diagnosed in 79.6% and 70.7% of patients respectively. Significant fibrosis …
and NAFLD were diagnosed in 79.6% and 70.7% of patients respectively. Significant fibrosis …
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
S Yamamura, M Eslam, T Kawaguchi, T Tsutsumi… - Liver International, 2020 - osti.gov
Abstract Background & Aims Diagnostic criteria for metabolic associated fatty liver disease
(MAFLD) have been proposed, but not validated. We aimed to compare the diagnostic …
(MAFLD) have been proposed, but not validated. We aimed to compare the diagnostic …
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
S Yamamura, M Eslam, T Kawaguchi… - … : official journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background & aims Diagnostic criteria for metabolic associated fatty liver disease (MAFLD)
have been proposed, but not validated. We aimed to compare the diagnostic accuracy of the …
have been proposed, but not validated. We aimed to compare the diagnostic accuracy of the …